Fujifilm partners Shanghai firm to seek China’s approval for Covid-19 drug

Fujifilm partners Shanghai firm to seek China’s approval for Covid-19 drug

FMT NEWS - Lifestyle·2020-10-22 14:45

TOKYO: Japan’s Fujifilm Holdings Corp said on Thursday it has partnered with Shanghai-based Carelink Pharmaceutical Co to seek approval in China for Avigan to treat Covid-19 and influenza.

Carelink will use Fujifilm’s data on Avigan’s treatment of novel coronavirus infections and influenza to seek imported drug approval in China, Fujifilm said in a statement. The two companies also plan to develop an injectable form of the drug.

……

Read full article on FMT NEWS - Lifestyle

Japan

Comments

Leave a comment in Nestia App